BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15684177)

  • 1. Menostar: a low-dose estrogen patch for osteoporosis.
    Obstet Gynecol; 2005 Feb; 105(2):432-3. PubMed ID: 15684177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estrogen replacement therapy in osteoporosis].
    Hirvonen E
    Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond bone mineral density: several factors define bone health.
    Ruhl C
    Nurs Womens Health; 2008 Jun; 12(3):249-51. PubMed ID: 18557856
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
    Greenspan SL; Emkey RD; Bone HG; Weiss SR; Bell NH; Downs RW; McKeever C; Miller SS; Davidson M; Bolognese MA; Mulloy AL; Heyden N; Wu M; Kaur A; Lombardi A
    Ann Intern Med; 2002 Dec; 137(11):875-83. PubMed ID: 12458987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen therapy in women with postmenopausal osteoporosis].
    Zarcone R; Carfora E; Sergio F; Bellini P; Longo M; Tartaglia E; Tomasillo G
    Minerva Ginecol; 1997; 49(7-8):355-9. PubMed ID: 9380298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone in osteoporosis.
    Purdie DW; Rees M
    J Br Menopause Soc; 2003 Dec; 9(4):175. PubMed ID: 15107263
    [No Abstract]   [Full Text] [Related]  

  • 7. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summaries for patients. Bone loss after stopping estrogen or alendronate therapy.
    Ann Intern Med; 2002 Dec; 137(11):I31. PubMed ID: 12459003
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis treatment: the point of view of the gynecologist].
    Lopes P
    Contracept Fertil Sex; 1998 Jun; 26(6):408-11. PubMed ID: 9691516
    [No Abstract]   [Full Text] [Related]  

  • 12. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
    Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
    Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis therapy in general practice. Which measure should be included?].
    Abendroth K
    MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monthly tablet in postmenopausal osteoporosis].
    Krankenpfl J; 2005; 43(7-10):216. PubMed ID: 16515288
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal osteoporosis.
    Selby P
    Curr Osteoporos Rep; 2004 Sep; 2(3):101-6. PubMed ID: 16036090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biweekly menopausal substitutive hormone therapy: effects on climacteric and prevention of osteoporosis].
    Zylberberg B; Dormont D
    Contracept Fertil Sex; 1996 Dec; 24(12):874-8. PubMed ID: 9026274
    [No Abstract]   [Full Text] [Related]  

  • 18. Denosumab for the management of postmenopausal osteoporosis.
    Singer A; Grauer A
    Postgrad Med; 2010 Nov; 122(6):176-87. PubMed ID: 21084794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What is reliable in the treatment of osteoporosis in menopausal women?].
    Ziegler R
    Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
    [No Abstract]   [Full Text] [Related]  

  • 20. Are lower doses of estrogen effective against osteoporosis?
    Healthc Demand Dis Manag; 1999 Aug; 5(8):125-7. PubMed ID: 10557953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.